| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/BF03349241 |
| P8608 | Fatcat ID | release_bequzzcwkrcgthslkn4s7wsjba |
| P698 | PubMed publication ID | 18250615 |
| P2093 | author name string | W Y Almawi | |
| I Ezzidi | |||
| N Mtiraoui | |||
| T Mahjoub | |||
| M Ben Hadj Mohamed | |||
| M Chaieb | |||
| P2860 | cites work | The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes | Q24290189 |
| Implication of the Pro12Ala polymorphism of the PPAR-gamma 2 gene in type 2 diabetes and obesity in the French population | Q24791420 | ||
| Haplotype analysis of the PPARgamma Pro12Ala and C1431T variants reveals opposing associations with body weight. | Q24799062 | ||
| The peroxisome proliferator-activated receptor-gamma2 Pro12Ala polymorphism | Q28216175 | ||
| The PPARG Pro12Ala polymorphism is associated with a decreased risk of developing hyperglycemia over 6 years and combines with the effect of the APM1 G-11391A single nucleotide polymorphism: the Data From an Epidemiological Study on the Insulin Resi | Q31035230 | ||
| Effect of the peroxisome proliferator-activated receptor-gamma 2 pro(12)ala variant on obesity, glucose homeostasis, and blood pressure in members of familial type 2 diabetic kindreds | Q31831156 | ||
| Free fatty acids, insulin resistance, and type 2 diabetes mellitus | Q33650385 | ||
| The Pro12Ala polymorphism in PPAR gamma2 may confer resistance to type 2 diabetes | Q33899154 | ||
| Type-2 diabetes: a cocktail of genetic discovery. | Q36599288 | ||
| A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity | Q38331543 | ||
| The peroxisome proliferator activated receptorgamma2 (PPARgamma2) Pro12Ala variant: lack of association with type 2 diabetes in obese and non obese Tunisian patients | Q39633896 | ||
| Peroxisome proliferator-activated receptor gamma 2 Pro12Ala gene variant is strongly associated with larger body mass in the Taiwanese. | Q40738571 | ||
| A functional variant in the peroxisome proliferator-activated receptor gamma2 promoter is associated with predictors of obesity and type 2 diabetes in Pima Indians | Q42800233 | ||
| Studies of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma2 (PPAR-gamma2) gene in relation to insulin sensitivity among glucose tolerant caucasians | Q43763530 | ||
| Effect of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor gamma-2 gene on adiposity, insulin sensitivity and lipid profile in the Spanish population | Q44172019 | ||
| Differential effects of the C1431T and Pro12Ala PPARgamma gene variants on plasma lipids and diabetes risk in an Asian population | Q44210344 | ||
| The Pro12Ala polymorphism of PPARγ2 gene and susceptibility to type 2 diabetes mellitus in a Polish population | Q44633761 | ||
| The Pro12Ala and C-681G variants of the PPARG locus are associated with opposing growth phenotypes in young schoolchildren | Q44640373 | ||
| The human peroxisome proliferator-activated receptor gamma2 (PPARgamma2) Pro12Ala polymorphism is associated with decreased risk of diabetic nephropathy in patients with type 2 diabetes | Q44666346 | ||
| Effects of peroxisome proliferator-activated receptor-gamma 2 Pro12Ala polymorphism on body fat distribution in female Korean subjects | Q45161738 | ||
| Molecular scanning of the human peroxisome proliferator activated receptor gamma (hPPAR gamma) gene in diabetic Caucasians: identification of a Pro12Ala PPAR gamma 2 missense mutation | Q46671380 | ||
| Differential expression of peroxisomal proliferator activated receptors alpha and delta in skeletal muscle in response to changes in diet and exercise. | Q46835676 | ||
| Association of Pro12Ala polymorphism in peroxisome proliferator-activated receptor gamma with Pre-diabetic phenotypes: meta-analysis of 57 studies on nondiabetic individuals. | Q51486794 | ||
| Association between Pro12Ala polymorphism of peroxisome proliferator-activated receptor-gamma 2 and myocardial infarction in the Chinese Han population. | Q51493325 | ||
| The peroxisome proliferator-activated receptor-gamma2 Pro12A1a variant: association with type 2 diabetes and trait differences. | Q51549887 | ||
| Single nucleotide polymorphisms of PPARD in combination with the Gly482Ser substitution of PGC-1A and the Pro12Ala substitution of PPARG2 predict the conversion from impaired glucose tolerance to type 2 diabetes: the STOP-NIDDM trial. | Q51798171 | ||
| Association of the Pro12Ala variant in the peroxisome proliferator-activated receptor-gamma2 gene with obesity in two Caucasian populations | Q57242012 | ||
| Hypoadiponectinaemia and high risk of type 2 diabetes are associated with adiponectin-encoding (ACDC) gene promoter variants in morbid obesity: evidence for a role of ACDC in diabesity | Q57249799 | ||
| Association of the Pro12Ala and C1431T variants of PPARG and their haplotypes with susceptibility to Type 2 diabetes | Q57639011 | ||
| Genetic Variation in PPARG Encoding Peroxisome Proliferator-Activated Receptor γ Associated With Carotid Atherosclerosis | Q58771200 | ||
| The mechanisms by which both heterozygous peroxisome proliferator-activated receptor gamma (PPARgamma) deficiency and PPARgamma agonist improve insulin resistance | Q74453774 | ||
| Identification of a novel peroxisome proliferator-activated receptor (PPAR) gamma promoter in man and transactivation by the nuclear receptor RORalpha1 | Q74507026 | ||
| Genetics of type 2 diabetes mellitus | Q81848581 | ||
| P433 | issue | 11 | |
| P921 | main subject | type 2 diabetes | Q3025883 |
| P304 | page(s) | 937-943 | |
| P577 | publication date | 2007-12-01 | |
| P1433 | published in | Journal of Endocrinological Investigation | Q15766847 |
| P1476 | title | Association of the peroxisome proliferator-activated receptor-gamma2 Pro12Ala but not the C1431T gene variants with lower body mass index in Type 2 diabetes | |
| P478 | volume | 30 |
| Q33430488 | Contribution of type 2 diabetes associated loci in the Arabic population from Tunisia: a case-control study |
| Q34474050 | Effects of PPARγ and RBP4 gene variants on metabolic syndrome in HIV-infected patients with anti-retroviral therapy |
| Q98164364 | PPARG (Pro12Ala) genetic variant and risk of T2DM: a systematic review and meta-analysis |
| Q34143718 | PPARG: Gene Expression Regulation and Next-Generation Sequencing for Unsolved Issues |
| Q37251406 | The C1431T polymorphism of peroxisome proliferator activated receptor γ (PPARγ) is associated with low risk of diabetes in a Pakistani cohort |
Search more.